Lucira Health, Inc. (LHDX) reported Q2 EPS of ($0.54), $0.09 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $28.43 million.
Lucira Health, Inc. (LHDX) reported Q2 EPS of ($0.54), $0.09 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $28.43 million.